Tofacitinib 5mg tablets
NHS hospitals in England used £19,600,295 of indicative cost of Tofacitinib 5mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 3.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Tofacitinib 5mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Tofacitinib 5mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Royal Devon & Exeter Nhs Foundation Trst | £529,514 |
| Norfolk & Norwich University Hpl Nhs Trt | £413,952 |
| Guy's & St Thomas' Nhs Foundation Trust | £408,433 |
| Royal Cornwall Hospitals Nhs Trust | £406,363 |
| King's College Hpl Nhs Foundation Trust | £369,625 |
| Derby Teaching Hospitals Nhs Found Trust | £368,984 |
| Cambridge Univ Hosp Nhs Foundation Trust | £362,208 |
| Royal Free London Nhs Foundation Trust | £351,169 |
| Hull And East Yorkshire Hpls Nhs Trust | £344,270 |
| The Royal Wolverhampton Nhs Trust | £340,131 |
The primary-care picture
Tofacitinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Tofacitinib medicine page.